Search Within
Document Type
83-43-2
Applied Filters:
Keyword:'83-43-2'
Showing 1-30 of 426 results for "83-43-2" within Technical Documents
SMC®Plate Washer Evaluation Kit
Plate Washer before Preventive Maintenance
1 2 3 4 5 6 7 8 9 10 11 12 Row Mean SD CV
A 57 41 69 41 84 63 55 92 90 87 73 100 71 20 28
MMP Activation Chart
1mM + MMP-7
(1:1)
37oC, 2-6h
43 42.6 F81VLTEG
6.5x
Imai et al., jbc270/1995/6691;
Reinemer et al., FEBS Lett.
1994/338/227
active-MMP-3 37oC; slow 43 42.6 low
MMP-1
Data Sheet - G9264
Growth-Associated Protein-43
(GAP-43, also known as B-50, F1, pp46, p57 and
neuromodulin), is an intracellular phosphoprotein found
exclusively in the peripheral and central nervous
systems.2 GAP-43 is a major protein
Data Sheet - G9264 - Lot 116H4810
Meiri, K., et al., J. Cell Biol., 112, 991 (1991).
2. Skene, J., Ann. Rev. Neurosci., 12, 127 (1989).
3. Meiri, K., et al., Proc. Natl. Acad. Sci. USA, 83,
3537 (1986).
4. Gordon-Weeks, P., Trends Neurosci
Quality Control Range Sheet- HCM1-106 and HCM1-206
Control 2 HCM1-206 43 – 90 ng/mL
Complement C4b Control 1 HCM1-106 9.8 – 20 ng/mL
Control 2 HCM1-206 47 – 97 ng/mL
Complement C5 Control 1 HCM1-106 21 – 43 ng/mL
Control 2
The Effective Use of Protein Kinase Inhibitors
108 100 95 83 87 88 76
101 96 28 34 77 28 29 63 104 91 9 92 42 94 111 94 70 22 72 104 101 84
87 110 29 12 12 49 66 28 94
Quality Control Ranges: Human Th17 Magnetic Bead Panel
21 - 43 pg/mL
Control 2 3.2 – 6.7 ng/mL Control 2 213 - 442 pg/mL
IL-9 Control 1 83 - 173 pg/mL
The Effective Use of Protein Kinase Inhibitors
108 100 95 83 87 88 76
101 96 28 34 77 28 29 63 104 91 9 92 42 94 111 94 70 22 72 104 101 84
87 110 29 12 12 49 66 28 94
Data Sheet - 17153
Milwankee, Wis. (1970)
4. C. Eloy, R. Lacrosse, Bull. Rech. Agron Gembloux,11(1-2):83 (1976)
5. G. Revter, Int. J. Food Microbiol., 2, 55-68 (1985)
6. J.E.L. Corry, G.D.W. Curtis, R.M. Baird, Culture Media
Data Sheet - SAB4200712
Roskoski R Jr., Pharmacol Res., 66, 105-43
(2012).
2. Seger R. and Krebs EG. FASEB J., 9, 726-35
(1995).
3. Pearson G., et al., Endocr Rev., 22, 153-83
(2001).
4. Fang JY. and Richardson
MultiScreen Filter Plates with Ultracel®-10 Membrane
142 176 140 136 138 131 123
Cyto c 122 131 124 119 118 123 124 117
FBS 79 70 57 43 42 54 67 72
Human 64 55 43 33 33 43 54 61
30 ABS 68 57 45
Data Sheet - SRP5208
26
43
72
95
130
170
56
34
References
1. Speck, O. et al., Moesin functions antagonistically
to the Rho pathway to maintain epithelial integrity.
Nature, 421(6918), 83-7 (2003).
Data Sheet - SRP5203
34
43
72
95
130
170
56
26
17
References
1. Wagner, P.D. et al., Regulation of the actin-
activated ATPase of aorta smooth muscle myosin.
J. Biol. Chem., 261(17), 7778-83 (1986)
MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors
42 157 2097
30 20 22 26 110 67 40 113 25 56 39 43 36 161 2056
std
5
53 27 42 42 129 127 42 146 42 83 63 78 41 196 5795
52
Data Sheet - 79214
respiratory enzymatic activity in the natural
aquatic environment ", Journal of Appl. Microbiol., 1997, 83, 43-52.
Precautions and Disclaimer
This product is for R&D use only
Product Information Sheet - C0773
.R., Anal.
Biochem., 113(2), 356-365 (1981).
5. McCarthy, R.C., et al., Transplant Proc., 43(6),
3171-3175 (2011).
6. Briete, A.G., et al., Transplant Proc., 43(9), 3171-
3175 (2011).
7
Data Sheet - S7064
of the
anti-DNA topoisomerase autoantibody response in
scleroderma. Arthritis Rheum., 43, 2733-2742
(2000).
2. Gussin, H.A., Anti-topoisomerase I (anti-Scl-70)
antibodies in patients with systemic
Quality Control Range Sheet- HST-111 and HST-211
20 pg/mL
Control 2 87 – 180 pg/mL Control 2 48 – 99 pg/mL
IL-13 Control 1 7.9 – 16 pg/mL MIP-1α Control
LABORATORY NOTEBOOK ISSUANCE PAGE
.9
04
83
.7
98
11
4.
82
11
8.
71
12
1.
76
12
7.
60
12
6.
90
13
1.
29
20
4.
38
20
7.
2
20
8.
98
(2
09
)
(2
10
)
(2
LABORATORY NOTEBOOK ISSUANCE PAGE
.9
04
83
.7
98
11
4.
82
11
8.
71
12
1.
76
12
7.
60
12
6.
90
13
1.
29
20
4.
38
20
7.
2
20
8.
98
(2
09
)
(2
10
)
(2
LABORATORY NOTEBOOK ISSUANCE PAGE
.9
04
83
.7
98
11
4.
82
11
8.
71
12
1.
76
12
7.
60
12
6.
90
13
1.
29
20
4.
38
20
7.
2
20
8.
98
(2
09
)
(2
10
)
(2
Product Information Sheet - A5666
References
1. The Merck Index, 12th ed., Entry# 537.
2. Ridings, J., et al., Purification of cord blood
lymphocytes. J. Immunol. Methods, 195(1-2),
43-48 (1996).
3. Kang, E. M., et al., Mobilization
Product Information Sheet - A0171
References
1. The Merck Index, 12th ed., Entry# 537.
2. Ridings, J., et al., Purification of cord blood
lymphocytes. J. Immunol. Methods, 195(1-2),
43-48 (1996).
3. Kang, E. M., et al., Mobilization
Data Sheet - S1076 - Lot SLBB2373
mM PMSF, and 25%
glycerol.
Molecular mass: ∼83 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 83–113 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for
Data Sheet - S1076 - Lot 109K0795
mM PMSF, and 25%
glycerol.
Molecular mass: ∼83 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 83–113 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for
Data Sheet - S1076 - Lot 040M0737
mM PMSF, and 25%
glycerol.
Molecular mass: ∼83 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 83–113 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for
Data Sheet - S1076 - Lot 031M0743
mM PMSF, and 25%
glycerol.
Molecular mass: ∼83 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 83–113 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for
Data Sheet - S1076 - Lot 100M0859
mM PMSF, and 25%
glycerol.
Molecular mass: ∼83 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 83–113 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for
Data Sheet - S1076
1 50
75
2 5
Figure 2.
Specific Activity of Typical Lot:
83–113 nmole/min/mg
Procedure
Preparation Instructions
Kinase Assay Buffer – 25 mM MOPS, pH 7.2, 12.5 mM
glycerol 2-phosphate, 20
Anti-Cannabinoid Receptor 1 (C1108)
Rev. Pharmacol.
Toxicol., 38, 179-200 (1998).
2. Twitchell, W., et al., J. Neurophysiol., 78, 43-50
(1997).
3. Tsou, K., et al., Neuroscience, 83, 393-411 (1998).
4. Pertwee, R.G., Curr. Med. Chem
Page 1 of 15